| Literature DB >> 28243813 |
K A Knight1, S J Moug2, M A West3.
Abstract
BACKGROUND: Exercise in the preoperative period, or prehabilitation, continues to evolve as an important tool in optimising patients awaiting major intra-abdominal surgery. It has been shown to reduce rates of post-operative morbidity and length of hospital stay. The mechanism by which this is achieved remains poorly understood. Adaptations in mesenteric flow in response to exercise may play a role in improving post-operative recovery by reducing rates of ileus and anastomotic leak. AIMS: To systematically review the existing literature to clarify the impact of exercise on mesenteric arterial blood flow using Doppler ultrasound.Entities:
Keywords: Cancer; Colorectal; Mesenteric blood flow; Prehabilitation
Mesh:
Year: 2017 PMID: 28243813 PMCID: PMC5360832 DOI: 10.1007/s10151-017-1589-9
Source DB: PubMed Journal: Tech Coloproctol ISSN: 1123-6337 Impact factor: 3.781
Study and participant characteristics
| References | Country | Journal | Patient number | Patient group | Mean age/weight/ |
|---|---|---|---|---|---|
| Peripheral and central vascular conductance influence on post-exercise hypotension | Japan | J Physiol Anthropol | 8 | Healthy volunteers | 20–32 years |
| Relationship between reduced lower abdominal blood flows and heart rate in recovery following cycling exercise | Japan | Acta Physiol | 11 | Healthy male volunteers | 24.7 ± 4.8 years |
| Are splanchnic hemodynamics related to the development of gastrointestinal symptoms in Ironman triathletes? | South Africa | Clin J Sport Med | 59 | Endurance athletes | Symptomatic group: |
| Differential arterial blood flow response of splanchnic and renal organs during low-intensity cycling exercise in women | Japan | Am J Physiol Heart Circ Physio | 8 | Female healthy volunteers | 21–30 years |
| Reproducibility of ultrasound blood flow measurement of the superior mesenteric artery before and after exercise | The Netherlands | Int J Sports Med | 12 | Male healthy volunteers | 25.9 ± 3.8 years |
| Involvement of the human splanchnic circulation in pressor response induced by handgrip contraction | Norway | Acta Physiol Scand | 7 | Healthy students | 23 ± 1 years |
| Reduced blood flow in abdominal viscera measured by Doppler ultrasound during one-legged knee extension | Japan | J Appl Physiol | 18 | Male healthy volunteers | 29 years (20–38) |
| Mesenteric, coeliac and splanchnic blood flow in humans during exercise | Denmark | J Physiol | 19 | Healthy volunteers | 28 years (24–35) |
| Hypotensive and regional haemodynamic effects of exercise, fasted and after food, in human sympathetic denervation | UK | Clin Sci (Lond) | 12 | Patients with autonomic failure | 56 years |
| Abnormal regional blood flow responses during and after exercise in human sympathetic denervation | UK | J Physiol | 17 | Eleven patients with autonomic failure | Patients: 57 ± 6 years |
| Systemic and regional (including superior mesenteric) haemodynamic responses during supine exercise while fasted and fed in normal man | UK | Clin Res | 10 | Healthy volunteers | 32 years (22–60) |
| Influence of central command and ergoreceptors on the splanchnic circulation during isometric exercise | Belgium | Eur J Appl Physiol Occup Physiol | 10 | Healthy volunteers | 21.1 years |
| Priority of blood flow to splanchnic organs in humans during pre- and post-meal exercise | Norway | Acta Physiol Scand | 5 | Healthy volunteers | Median age 23 |
| Abnormality of superior mesenteric artery blood flow responses in human | UK | J Physiol | 23 | Thirteen patients autonomic failure; | Patients: |
| Regional blood flow in chronic heart failure: the reason for the lack of correlation between patients’ exercise tolerance and cardiac output? | UK | Br Heart J | 40 | Thirty patients with chronic heart failure (27 males) | Patients: 67 years |
| Effects of exercise on mesenteric blood flow in man | UK | Gut | 46 | Healthy volunteers | Fasting group: |
Exercise intervention details according to the frequency, intensity, timing and type (FITT) principle
| References | Frequency | Intensity | Timing | Type |
|---|---|---|---|---|
| Endo et al. [ | Single episode | 60% of heart rate (HR) reserve | 60 min | Ergometer cycling |
| Osada et al. [ | 3 × 12 min session at different target intensities | 30, 50 and 85% VO2max | 3 min each at 1/3 then 2/3 max intensity, | Ergometer cycling |
| Wright et al. [ | – | – | – | Triathlon: |
| Endo et al. [ | ×3 interspersed with 30 min rest periods | 40 W | 4 min | Ergometer cycling |
| Peters et al. [ | x2 interspersed with 5 min rest period | 70% VO2max | 30 min | Ergometer cycling |
| Waaler et al. [ | x2 pressor tests separated by 10 min interval | 40% max voluntary contraction | 2 min | Sustained handgrip |
| Osada et al. [ | Ten cycles per minute | Low-intensity exercise (HR | 20 min | Knee extension–flexion |
| Perko et al. [ | Two episodes | 75% VO2 max | Not stated | Fasting and |
| Puvi-Rajasingham et al. [ | 2 × 9 min session (fasting and postprandial) | 25, 50 and 75 W (3 min each) | 9 min | Supine cycling |
| Puvi-Rajasingham et al. [ | Single session | 25, 50 and 75 W (3 min each) | 9 min | Supine cycling |
| Puvi-Rajasingham et al. [ | Two sessions separated by 2 days | 25, 50 and 75 W (3 min each) | 9 min | Ergometer cycling |
| Duprez et al. [ | Single episode | 30% maximal voluntary contraction | 90 s | Ischaemic handgrip |
| Eriksen and Waaler [ | Two sessions separated by 8 min rest | 50–65 W and 150–200 W | 4 min each | Semi-supine cycling |
| Chaudhuri et al. [ | Single session | 1/3 maximal pressure | 120 s | Isometric exercise |
| Muller et al. [ | Single session | 2.7 km/h at varying slope angles (0, 1.3, 2.7) | 4 min at each angle | Submaximal treadmill exercise |
| Qamar and Read [ | Single session | 5 km/h 20% gradient | 15 min | Walking (treadmill) |
Results according to impact on mesenteric flow
| References | Pretest conditions | Target vessel | Parameter studied | Effect on perfusion |
|---|---|---|---|---|
|
| ||||
| Eriksen and Waaler [ | Fasted for 12 h | SMA | Flow = product of average velocity and vascular cross-sectional area | ↑SMA flow following fasting exercise, SMA conductance ↓ after exercise in fed state but flow maintained at resting values |
|
| ||||
| Endo et al. [ | 3 h fast | SMA (renal, brachial & femoral) | SMA blood flow (vascular conductance) | Vascular conductance of SMA same as pre-exercise levels |
| Endoet al. [ | 3 h fast | SMA, renal and splenic arteries | SMA RI (MBV/MAP) | SMA MBV close to resting values |
|
| ||||
| Qamar and Read [ | Overnight fast | SMA | No details | SMABF ↓ in fasting state, mild ↑following exercise + meal, SMABF ↑ at 5 min but no other time in meal only group |
| Puvi-Rajasingham et al. [ | Overnight fast | SMA | Flow = | SMA blood flow fell in controls throughout exercise, while only reduced in patients with AF after 9 min |
| Chauduri et al. [ | Overnight fast | SMA | SMA flow = | No significant change in SMA flow or resistance in patients with sympathetic failure; ↑SMA resistance and ↓flow in controls |
| Osada et al. [ | No details | Abdominal aorta and femoral arteries | SMA flow (blood velocity, vessel diameter) | Reduced blood flow as VO2 max increased but ↑ blood flow below 30% VO2 max |
| Wright et al. [ | No details | SMA and coeliac arteries | Vessel diameter, systolic and diastolic velocity, resistance index | ↓ diameter and RI with ↑diastolic velocity post-race |
| Peters et al. [ | Fasted 3 h | SMA | Blood flow rate = TAMV x π x 4−1 x d2 | Blood flow decreased immediately after exercise by 49% and 38% |
| Waaler et al. [ | Fasting 12 h | SMA | SMA conductance = SMA flow/MAP | Reduced SMA vascular conductance during pressor response; less marked postprandially |
| Osada et al. [ | 10 h fast pretest | Abdominal aorta and femoral arteries | Visceral blood flow = BF aorta–(BFRCFA + BFLCFA) | Visceral blood flow dropped significantly even at low work rates |
| Perko et al. [ | Overnight fast pretest | SMA | Blood flow = TAMV x π x 4−1 x d2 | 25% reduction in mesenteric flow during submaximal cycling |
| Puvi-Rajasingham et al. [ | Medication omitted 72 h | SMA | SMA vascular resistance = MAP/flow | Slower increase in SMA vascular resistance in AF following fasted exercise; Less SMA vasoconstriction during postprandial exercise |
| Puvi-Rajasingham et al. [ | Test 1: overnight fast | SMA flow and vascular resistance | Flow = | ↑SMA flow at rest, |
| Duprez et al. [ | Overnight fast | SMA | Pulsatility index | ↓SMA PI during and at end of exercise |
Timing of assessments of mesenteric flow
| Study | Pre-exercise assessment | Assessment during exercise | Post-exercise assessment |
|---|---|---|---|
| Endo et al. [ | 25–40 min | – | Post 1: 15-30 min |
| Osada et al. [ | Time not stated | – | Every 45 s until 3 min, alternate minutes between 4–14 min |
| Wright et al. [ | Up to 3 days prerace | – | Upon race completion |
| Endo et al. [ | Not stated | Ten points in first 2 min; every 30 s for 2 min | Every 30 s for 3 min |
| Peters et al. [ | Three times in 25 min rest period | – | Test 1: immediately following 30 min cycling |
| Waaler et al. [ | 2 min intervals for 5 min | During last 20 s of 2 min test | 2 min intervals for 5 min |
| Osada et al. [ | One resting measurement | Every 5 min for 20 min | At 1 min, between 2 and 5 min |
| Perko et al. [ | One resting measurement | One measurement during exercise | 2 min after cycling |
| Puvi-Rajasingham et al. [ | Time not specified | At 3, 6 and 9 min | At 2, 5 and 10 min |
| Puvi-Rajasingham et al. [ | Time not specified | At 3, 6 and 9 min | At 2, 5 and 10 min |
| Puvi-Rajasingham et al. [ | Time not specified | At 3, 6 and 9 min | At 2, 5 and 10 min |
| Duprez et al. [ | Continuously 3 min | Continuously for 90 s | Continuously for 3 min |
| Eriksen et al. [ | During final 2 min of 20 min rest | During the final 2 min at end of 4 min cycle | During final 2 min of 8 min rest period |
| Chauduri et al. [ | 10 min prior | At 120 s | – |
| Muller et al. [ | – | – | – |
| Qamar et al. [ | After 30 min rest | – |
|
AF autonomic failure, BP blood pressure, CO cardiac output, MAP mean arterial pressure, MBV mean blood volume, LCFA left common femoral artery, RCFA right common femoral artery, RI resistance index, SMA superior mesenteric artery, SMABF superior mesenteric artery blood flow, SVR systemic vascular resistance, TAMV time-averaged mean velocity, TAV time-averaged velocity, USS ultrasound
Pubmed literature review search conducted on 24.02.16
| No. | Query | Expected results |
|---|---|---|
| #1 | Hemodynamic* [tiab] OR Haemodynamic* [tiab] OR (blood [tiab] AND velocity* [tiab]) OR (blood* [tiab] AND flow* [tiab]) | 332,083 |
| #2 | Exercis* [tiab] OR (physical* [tiab] AND fitness [tiab]) OR (physical* [tiab] AND extert* [tiab]) OR (physical* [tiab] AND fit* [tiab]) | 227,879 |
| #3 | Doppler [tiab] | 85,215 |
| #4 | (Splanchni* [tiab] OR mesenter* [tiab]) | 57,027 |
| #5 | (#1 AND #2 AND #3 AND #4) | 33 |
| #6 | “Exercise”[Mesh] OR “Exercise Therapy”[Mesh] OR “Physical Exertion”[Mesh] OR “Physical Fitness”[Mesh] | 206,385 |
| #7 | “Hemodynamics”[Mesh] OR “Blood Flow Velocity”[Mesh] OR “Regional Blood Flow”[Mesh] | 610,249 |
| #8 | “Splanchnic Circulation”[Mesh] OR “Mesenteric Arteries”[Mesh] | 28,105 |
| #9 | “Ultrasonography, Doppler”[Mesh] | 57,969 |
| #10 | (#6 AND #7 AND #8 AND #9) | 8 |
| #11 | 8,036,905 [uid] | 1 |
| #12 | 13,356,576 [uid] | 1 |
| #13 | 3,596,339 [uid] | 1 |
| #14 | 9,824,727 [uid] | 1 |
| #15 | Similar articles for PubMed (Select 8,036,905) | 102 |
| #16 | Similar articles for PubMed (Select 13,356,576) | 101 |
| #17 | Similar articles for PubMed (Select 3,596,339) | 119 |
| #18 | Similar articles for PubMed (Select 9,824,727) | 106 |
| #19 | (#15 OR #16 OR #17 OR #18) | 343 |
| #20 | (#5 OR #10) NOT #19 | 23 |
| #21 | (#5 OR #10) NOT #19 Filters: English | 23 |
| #22 | #19 Filters: Humans; English | 204 |
| #23 | #22 OR #21 | 227 |
Quality assessment using Down’s and Black Checklist
| Endo et al. [ | Osada et al. [ | Wright et al. [ | Endo et al. [ | Peters et al. [ | Waaler et al. [ | Osada et al. [ | Perko et al. [ | Puvi-Rajasingham et al. [ | Puvi-Rajasingham et al. [ | |
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Is the hypothesis/aim/objective of the study clearly described? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Are the main outcomes to be measured clearly described in the introduction or methods section? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Are the characteristics of the patients included in the study clearly described? | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Are the interventions of interest clearly described? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Are the distributions of principal confounders in each group of subjects to be compared clearly described? | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Are the main findings of the study clearly described? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Does the study provide estimates of the random variability in the data for the main outcomes? | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
| Have all important adverse events that may be a consequence of the intervention been reported? | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Have the characteristics of patients lost to follow-up been described | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Have actual probability values been reported for the main outcomes except where the probability value is less than 0.001? | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
|
| ||||||||||
| Were the subjects asked to participate in the study representative of the entire population from which they were recruited? | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Were those subjects who were prepared to participate representative of the entire population from which they were recruited? | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive? | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
|
| ||||||||||
| Was an attempt made to blind study subjects to the intervention they have received? | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Was an attempt made to blind those measuring the main outcomes of the intervention? | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| If any of the results of the study were based on data dredging, was this made clear? | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 |
| In trials and cohort studies, do the analyses adjust for different lengths of follow-up of patients, or in case–control studies, is the time period between the intervention and outcome the same for case controls? | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Were the statistical tests used to assess the main outcomes appropriate? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Was compliance with the intervention/s reliable? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Were the main outcome measures used accurate (valid and reliable)? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
|
| ||||||||||
| Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case–control studies) recruited from the same population? | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case–control studies) recruited over the same period of time? | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Were the study subjects randomised to intervention groups? | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Was the randomised intervention assignment concealed from both patients and health care staff until recruitment was complete and irrevocable? | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Was there adequate adjustment for confounding in the analyses from which the main findings were drawn? | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Were losses of patients to follow-up taken into account? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
|
| ||||||||||
| Did the study have sufficient power to detect a clinically important effect where the probability value for a difference being due to chance is less than 5%? | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 19 | 12 | 12 | 11 | 12 | 12 | 16 | 14 |